Lord’s Marks Historic Collaboration with CMET to Develop World’s First AI-Based Breast Cancer Detection Device

Mumbai (Maharashtra) [India], March 11: Lord’s Mark Industries Limited has entered into a Technology Transfer Agreement with the Centre for Materials for Electronic Technology (CMET) to manufacture an AI-powered, radiation-free Breast Screening Wearable Device for early detection of breast cancer.

India ranks third globally in new breast cancer incidence after China and the US, with the disease accounting for over 26% of all female cancers in the country. The global breast cancer market was valued at USD 4,882.14 million in 2024 and is projected to reach USD 12,880.85 million by 2035 at a CAGR of 9.22% (MRFR).